Association of Molecular Characteristics with Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Checkpoint Inhibitors

OBJECTIVES: Immune checkpoint inhibitors (ICIs) have changed the landscape of lung cancer therapy. However significant proportions of patients have primary or acquired resistance to ICIs. Molecular characterization is critical for patient selection and overcoming resistance to checkpoint inhibitors....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer
Main Authors: Zhao, Dan, Mambetsariev, Isa, Li, Haiqing, Chen, Chen, Fricke, Jeremy, Fann, Patricia, Kulkarni, Prakash, Xing, Yan, Lee, Peter P., Bild, Andrea, Massarelli, Erminia, Koczywas, Marianna, Reckamp, Karen, Salgia, Ravi
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8158847/
https://ncbi.nlm.nih.gov/pubmed/32554069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2020.05.025
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados